Astrazeneca PLC

(AZN) Trade

By |

Profile

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology, and neuroscience. The majority of sales come from international markets with the United States representing close to one third of its sales.

Contact Information

Website: www.astrazeneca.com
Email: ir@astrazeneca.com
Main Phone: +44 2037495000
Address: 1 Francis Crick Avenue
Address 2: Cambridge Biomedical Campus
City / Town: Cambridge
Country: GBR
Postal Code: CB2 0AA

Issuer Information

Exchange: NYE
CEO: Pascal Soriot
Employees: 64600
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More

Profile

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology, and neuroscience. The majority of sales come from international markets with the United States representing close to one third of its sales.

Contact Information

Website: www.astrazeneca.com
Email: ir@astrazeneca.com
Main Phone: +44 2037495000
Address: 1 Francis Crick Avenue
Address 2: Cambridge Biomedical Campus
City / Town: Cambridge
Country: GBR
Postal Code: CB2 0AA

Issuer Information

Exchange: NYE
CEO: Pascal Soriot
Employees: 64600
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
$ 47.92 $ -0.27 (-0.56%)
Last Price 47.92 Change $ -0.27 Change % -0.56 Tick N/A
Bid 48.88 Bid Size 300.00 Ask 48.94 Ask Size 400.00
Open 48.05 High 48.50 Low 47.74 Prev Close 48.19
Last Trade Volume 1.9 mi 52 Wk Hi 49.22 52 Wk Low 35.30
Market Cap 125.7 bi Ex-Div Date Div Rate 0.90 Yield 1.8780
Shares 2,623,826,536.00 EPS (TTM) 0.95 PE Ratio 59.50 Exchange NYSE
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 42 42 42 42
Low Target Price Estimate 37 37 37 37
Mean Target Price Estimate 38.85 38.85 38.85 38.85
Standard Deviation 2.18 2.18 2.18 2.18
Date of Most Recent Estimate 05/18/18 05/18/18 05/18/18 05/18/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 7 7 7 6
Moderate Buy 0 0 0 0
Hold 1 1 1 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.25 1.25 1.25 1.8